EVER elusive, yet another drug that showed great promise for treatment of Alzheimer's Disease (AD) has failed in late phase studies.
Lundbeck's idalopirdine showed no benefits in Phase III clinical trials, published in JAMA - see jamanetwork.com for the study.
THE Pharmacy Board of Australia has opened public consultation on the draft registration standards and guidelines for a proposed Endorsement for scheduled medicines for pharmacists.
AS the Federal Government enters final negotiations for the First Pharmacy Programs Agreement (1PPA), the Remote and Isolated Pharmacist Association Australia (RIPAA) is calling for a dedicated funding pilot to support resident clinical pharmacists in Australia’s most isolated communities.
UK-BASED organisation GenM founder Heather Jackson (pictured) is on a mission to support pharmacies helping women through menopause with its MTick certification and accreditation.